US Implementation of GHTF (Global Harmonisation Task Force) recommendations is likely to be problematic
This article was originally published in Clinica
Executive Summary
It would be difficult for the FDA to implement all of the documents approved by the Global Harmonisation Task Force (GHTF) because some of the recommendations conflict with US law, said panel participants at last month's Food and Drug Law Institute video conference.